TRANSCODE THERAPEUTICS, INC. (RNAZ) Capital expenditures 2021–2025
TRANSCODE THERAPEUTICS, INC. (RNAZ) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$6,660FY2025 · since FY2021: $254,820 → $6,660
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6,660 | -69.4% |
| FY2024 | $21,761 | -38.9% |
| FY2023 | $35,609 | -64.7% |
| FY2022 | $100,919 | -60.4% |
| FY2021 | $254,820 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice